CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Capricor rises as FDA extends Deramiocel action date

RegulatoryDeramiocelPositive
AI Analysis

Summary

Capricor's stock rose following FDA's extension of the action date for Deramiocel. The extension indicates a regulatory timeline adjustment for the drug's review process.

Outcome Details

FDA extended action date

Importance:6/10
Sentiment:
0.40
FDAregulatoryextensionDeramiocel
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 24, 2026 2:27 PM

Read Original